NYSE American · RGNT

Regentis Biomaterials news

$1.85−2.12%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0

About Regentis Biomaterials

Regentis Biomaterials Slips 9% After Soaring 506% On Monday — Here's Why RGNT Stock Is Trending
BenzingaJun 16, 1:31 AM ET▼ Negative

While the stock experienced an intraday surge of 506%, the withdrawal of the public offering registration statement and decision not to pursue the offering represents a negative development for the company's capital raising plans. The subsequent 9% after-hours decline and Benzinga's Edge Stock Rankings indicating a negative price trend across all timeframes further support a negative sentiment outlook.

Also mentions RGNT

Articles that tag RGNT but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology